These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 9182303

  • 1. Protection by taurine against adriamycin-induced proteinuria and hyperlipidemia in rats.
    Venkatesan N, Venkatesan P, Karthikeyan J, Arumugam V.
    Proc Soc Exp Biol Med; 1997 Jun; 215(2):158-64. PubMed ID: 9182303
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of the lipoprotein lipase activator NO-1886 on adriamycin-induced nephrotic syndrome in rats.
    Nakayama K, Hara T, Kusunoki M, Tsutsumi K, Minami A, Okada K, Sakamoto S, Ohnaka M, Miyata T, Nakamura T, Aoki T, Fukatsu A, Nakaya Y, Kakumu S.
    Metabolism; 2000 May; 49(5):588-93. PubMed ID: 10831167
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hyperlipidemic nephropathy induced by adriamycin: effect of melatonin administration.
    Montilla P, Túnez I, Muñoz MC, López A, Soria JV.
    Nephron; 1997 May; 76(3):345-50. PubMed ID: 9226237
    [Abstract] [Full Text] [Related]

  • 6. Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome.
    Vaziri ND, Liang KH.
    Circulation; 2004 Jul 27; 110(4):419-25. PubMed ID: 15262831
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of Astragalus Angelica Mixture on lipoprotein lipase and lecithin cholesterol acyltransferase of nephrotic rats].
    Li N, Li J, Xin G.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1999 Aug 27; 19(8):484-6. PubMed ID: 11783230
    [Abstract] [Full Text] [Related]

  • 9. [The effect of lovastatin on the development of adriamycin nephropathy in rats].
    Tesar V, Zima T, Poledne R, Stejskalová A, Tĕmínová J, Stípek S.
    Sb Lek; 1995 Aug 27; 96(1):35-42. PubMed ID: 8711364
    [Abstract] [Full Text] [Related]

  • 10. ICRF-187 (dexrazoxan) protects from adriamycin-induced nephrotic syndrome in rats.
    Zima T, Tesar V, Crkovská J, Stejskalová A, Pláteník J, Temínová J, Nemecek K, Janebová M, Stípek S.
    Nephrol Dial Transplant; 1998 Aug 27; 13(8):1975-9. PubMed ID: 9719150
    [Abstract] [Full Text] [Related]

  • 11. [Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome].
    Tesar V, Zima T, Jirsa M, Crkovská J, Stípek S, Vernerová Z, Seráková M.
    Cas Lek Cesk; 1999 Oct 20; 138(18):560-4. PubMed ID: 10596472
    [Abstract] [Full Text] [Related]

  • 12. Investigation of the role of serum lipoprotein-associated peroxides in Adriamycin cardiotoxicity. Release of reduced glutathione from rat hearts perfused with lipase-hydrolyzed very low density lipoprotein fractions obtained from Adriamycin-treated and control rats.
    Thayer WS.
    Biochem Pharmacol; 1989 Jun 15; 38(12):1923-9. PubMed ID: 2742600
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Protective role of melatonin and retinol palmitate in oxidative stress and hyperlipidemic nephropathy induced by adriamycin in rats.
    Montilla PL, Túnez IF, Muñoz de Agueda C, Gascón FL, Soria JV.
    J Pineal Res; 1998 Sep 15; 25(2):86-93. PubMed ID: 9755029
    [Abstract] [Full Text] [Related]

  • 16. [Disorders of lipid metabolism in patients with nephrotic syndrome].
    Zdrojewski Z.
    Pol Tyg Lek; 1998 Sep 15; 47(31-33):696-9. PubMed ID: 1492041
    [No Abstract] [Full Text] [Related]

  • 17. Effects of omega-aminosulfonic acids on lipid metabolism in dietary hyperlipidemic rats.
    Yamada J, Masuda M, Tanaka M, Horisaka K.
    J Pharmacobiodyn; 1983 Jun 15; 6(6):373-80. PubMed ID: 6631658
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of HMG-CoA reductase inhibition on hepatic expression of key cholesterol-regulatory enzymes and receptors in nephrotic syndrome.
    Vaziri ND, Liang K.
    Am J Nephrol; 2004 Jun 15; 24(6):606-13. PubMed ID: 15583480
    [Abstract] [Full Text] [Related]

  • 20. Attenuation of abnormalities in the lipid metabolism during experimental myocardial infarction induced by isoproterenol in rats: beneficial effect of ferulic acid and ascorbic acid.
    Yogeeta SK, Hanumantra RB, Gnanapragasam A, Senthilkumar S, Subhashini R, Devaki T.
    Basic Clin Pharmacol Toxicol; 2006 May 15; 98(5):467-72. PubMed ID: 16635105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.